SELLAS Life Sciences Group, Inc. (SLS) Earnings
|
Expand Research on SLS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +24.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +11.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/26  |
Q425 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 | Q325 | -$0.06 | -$0.08 | +$0.02 | N/A | N/A | N/A |  | | Details | |
| 8/12/25 |
Q225 | -$0.07 | -$0.08 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 8/7/25 |
Q225 | N/A | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 | Q125 | -$0.07 | -$0.11 | +$0.04 | N/A | N/A | N/A | | | Details | |
| 5/12/25 |
Q125 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/25 |
Q125 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/8/25 |
Q125 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A |
